Cargando…
Potential role of tigecycline in the treatment of community-acquired bacterial pneumonia
Tigecycline is a member of the glycylcycline class of antimicrobials, which is structurally similar to the tetracycline class. It demonstrates potent in vitro activity against causative pathogens that are most frequently isolated in patients with community-acquired bacterial pneumonia (CABP), includ...
Autores principales: | Townsend, Mary L, Pound, Melanie W, Drew, Richard H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108749/ https://www.ncbi.nlm.nih.gov/pubmed/21694911 http://dx.doi.org/10.2147/IDR.S6030 |
Ejemplares similares
-
Tigecycline in the treatment of complicated intra-abdominal and complicated skin and skin structure infections
por: Townsend, Mary L, et al.
Publicado: (2007) -
Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia
por: Tanaseanu, Cristina, et al.
Publicado: (2009) -
Switch therapy in hospitalized patients with community-acquired pneumonia: Tigecycline vs. Levofloxacin
por: Ramirez, Julio A, et al.
Publicado: (2012) -
Tigecycline Versus Levofloxacin in Hospitalized Patients
With Community-Acquired Pneumonia: An Analysis of
Risk Factors
por: Dartois, Nathalie, et al.
Publicado: (2013) -
Community-Acquired Pneumonia, Bacterial
por: File, Thomas M.
Publicado: (2012)